MAP2K7 and glioblastoma: Connectivity Map (CMap) analysis further identified MEK inhibitors as preliminary candidate compounds for specific subtypes.<h4>Discussion</h4>These findings support an association between ERS-related epigenetic modifications and GBM heterogeneity, and provide an epigenetic framework for refined molecular stratification and further exploration of subtype-related therapeutic strategies.